查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840858

智慧切片檢查設備市場按產品類型、應用、引導技術、最終用戶和組件分類－2025年至2032年全球預測

Smart Biopsy Devices Market by Product Type, Application, Guidance Technology, End User, Component - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，智慧切片檢查設備市場規模將達到 91.1 億美元，複合年成長率為 6.52%。

關鍵市場統計數據
基準年 2024 54.9億美元
預計年份：2025年 58.5億美元
預測年份 2032 91.1億美元
複合年成長率 (%) 6.52%

一份簡明指南，闡述了影像創新、手術效率和臨床需求如何融合，從而塑造現代切片檢查設備策略。

智慧切片檢查設備的發展現況是臨床需求與技術能力相互融合的產物，需要精心的策略規劃。影像技術、針頭設計和引導軟體的進步正在提高診斷準確性，同時也在重塑醫療機構的流程。隨著臨床醫生追求微創手術，以期獲得更好的組織採集效果並降低患者風險，設備開發商和醫療系統也在積極轉型，透過整合自動化平台、即時影像引導和可互通的軟體棧，簡化規劃、導航和文件記錄流程。

在此背景下，監管和報銷途徑持續影響著產品開發進度和市場接受度，使得供應鏈韌性和零件採購成為一項準策略性要務。因此，從製造商到醫院採購團隊的相關人員必須在臨床性能、可製造性、成本和售後支援之間取得平衡。此外，來自相鄰診斷成像和手術導引市場的技術創新相互借鑒，正在加速產品功能集的完善，並催生以分析和結果追蹤為中心的新型經營模式。

綜上所述，這些動態凸顯了高階主管整合的重要性，這種整合既要關注近期營運，又要關注長期戰略佈局——為決策者提供簡潔而全面的指導，幫助他們了解影響設備發展的各種因素、推動臨床應用的因素，以及在日益複雜的生態系統中保持優勢所需的競爭應對措施。

技術、臨床工作流程和商業性的重大變革正在重塑切片檢查設備的競爭定位和市場推廣路徑。

過去幾年，臨床實踐和產品開發領域發生了加速的變革性轉變，從根本上改變了智慧切片檢查設備的競爭格局。首先，影像引導探查已從輔助功能轉變為核心功能，推動了硬體、軟體和資料分析之間更深層的整合。因此，製造商優先開發模組化平台，這些平台可容納多種影像輸入，並能透過回饋迴路實現確定性的針頭定位，從而減少操作者之間的差異。

其次，工作流程最佳化已成為一項商業性差異化因素。能夠縮短手術時間、降低併發症發生率並簡化文件記錄的程序正在被系統層面廣泛採用。因此，以使用者為中心的介面、自動針頭定位選項以及支援流程標準化的雲端文件等設計理念正變得日益重要。第三，與數位醫療的整合正在催生新的可獲利服務（軟體即服務模式、影像分析訂閱、結果追蹤模組），以增加設備收入並深化客戶關係。

最後，競爭格局正在改變。規模較小、反應更敏捷的參與企業正致力於開發小眾臨床應用或新型針頭幾何形狀，而成熟的醫療技術公司則利用其規模優勢，將設備、成像系統和服務協議捆綁銷售。影像處理供應商、軟體開發商和手術設備製造商之間的夥伴關係日益普遍，這反映出人們認知到，在複雜的臨床路徑中，整合解決方案才是致勝之道。總而言之，這些變化要求相關人員重新思考其產品藍圖、臨床檢驗策略和市場推廣模式，以實現臨床價值和經濟效益的雙重提升。

2025 年關稅調整如何影響醫療器材製造和臨床應用路徑的供應鏈、採購行為和產品策略

2025年宣布的一系列關稅措施的累積影響，對智慧切片檢查價值鏈的供應鏈配置和成本結構產生了切實的營運和策略影響。影響醫療設備組件和精密合金的關稅迫使製造商重新評估其供應商組合，加快在免稅地區的供應商資質認證，並考慮本地組裝以降低不斷上漲的土地成本。由於企業試圖規避供應中斷和財務不確定性，這些調整往往導致計劃管理成本增加和庫存積壓。

此外，關稅環境也影響了終端使用者的採購行為。面對資本預算的限制，醫院和診斷中心越來越關注整體擁有成本（不僅包括購買成本，還包括維護、耗材以及設備選擇帶來的後續影響）。為此，供應商優先考慮提高組件採購和生命週期成本的透明度，一些供應商還提案替代性的商業條款，例如耗材捆綁包和服務捆綁協議，以保持競爭力。

從產品創新角度來看，關稅情勢正在加速兩種顯著的因應措施。首先，在臨床可接受的情況下，開發人員正在尋求簡化設計和材料替代，以減少對高關稅投入品的依賴。其次，他們優先考慮透過對關稅波動不敏感的軟體和服務層來實現差異化，從而保護淨利率並維持價值獲取。隨著企業尋求在監管合規、成本穩定和不間斷的臨床供應之間取得平衡，製造地轉移和供應商多元化很可能仍將是積極的管理重點。

透過深度細分主導的分析，揭示產品、應用、引導技術、最終用戶和組件之間的差異將如何影響臨床和商業性路徑。

細分市場分析提供了一種結構化的視角，用於識別臨床需求、技術能力和市場機會的交集。根據產品類型，市場參與企業將平台分為自動化平台和手動平台。自動化平台提供工作流程的一致性，而手動設備則提供許多操作者熟悉的操作流程。這種二分法會影響產品設計和培訓投入，因為自動化解決方案需要更緊密的軟硬體整合，而手動平台則更注重人體工學和觸覺回饋。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧技術應用於即時影像導引切片檢查決策
  • 開發一種內建感測器的切片穿刺針，用於精確的組織表徵和回饋
  • 引入機器人輔助切片檢查平台將提高手術準確性和工作流程效率。
  • 即時切片檢查樣本分析和決策支援的照護現場綜合分子診斷技術的出現
  • 磁振造影超音波融合技術在智慧切片檢查系統中的應用日益廣泛，用於標靶癌症檢測
  • 擴展雲端基礎的數據管理和遠端醫療整合，以進行遠端切片檢查程序監測
  • 監管核准和報銷範圍擴大將影響智慧切片檢查設備市場的成長動態。
  • 用於自動病灶檢測和切片檢查靶點推薦的深度學習演算法的進展

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按產品類型分類的智慧切片檢查設備市場

  • 自動化
  • 手動的

第9章 按應用分類的智慧切片檢查設備市場

  • 胸部
  • 肝
  • 肺
  • 攝護腺

第10章：智慧切片檢查設備市場指導技術

  • CT導板
  • MRI 指南
  • 超音波引導

第11章 智慧切片檢查設備市場（按最終用戶分類）

  • 門診手術中心
  • 診所
  • 診斷中心
  • 醫院

第12章 智慧切片檢查設備市場（按組件分類）

  • 配件
  • 導航軟體
  • 影像系統
  • 針
    • 大軌距
    • 中型軌
    • 小軌距

第13章 智慧切片檢查設備市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 智慧切片檢查設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國智慧切片檢查設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • General Electric Company
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Hologic, Inc.
    • Fujifilm Holdings Corporation
    • Hitachi, Ltd.
    • Becton, Dickinson and Company
    • Cook Medical LLC
    • Merit Medical Systems, Inc.
Product Code: MRR-221461476EF5

The Smart Biopsy Devices Market is projected to grow by USD 9.11 billion at a CAGR of 6.52% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.49 billion
Estimated Year [2025] USD 5.85 billion
Forecast Year [2032] USD 9.11 billion
CAGR (%) 6.52%

A concise orientation to the convergence of imaging innovation, procedural efficiency, and clinical demand reshaping modern biopsy device strategies

The smart biopsy device landscape is converging clinical necessity and technological capability in ways that demand close strategic attention. Advances in imaging modalities, needle design, and guidance software are increasing diagnostic precision while reshaping procedural workflows across care settings. As clinicians push for minimally invasive techniques with improved tissue acquisition and reduced patient risk, device developers and health systems are adapting through integration of automated platforms, real-time imaging guidance, and interoperable software stacks that streamline planning, navigation, and documentation.

Against this backdrop, regulatory scrutiny and reimbursement pathways continue to influence product development timelines and adoption curves, while supply chain resilience and component sourcing have become quasi-strategic imperatives. Stakeholders from manufacturers to hospital procurement teams must therefore balance clinical performance with manufacturability, cost, and post-market support. In addition, the cross-pollination of innovations from adjacent imaging and surgical navigation markets is accelerating feature sets and creating new business models centered on analytics and outcomes tracking.

Taken together, these dynamics underscore the importance of a focused executive-level synthesis that highlights both the near-term operational levers and the longer-term strategic bets. The aim is to provide decision-makers with a concise yet comprehensive orientation to the forces shaping device evolution, adoption drivers across clinical settings, and the competitive responses required to maintain advantage in an increasingly sophisticated ecosystem.

Critical technological, clinical workflow, and commercial shifts that are remaking competitive positioning and adoption pathways for biopsy devices

Over the past several years, transformative shifts have accelerated in clinical practice and product development, producing a fundamentally different competitive landscape for smart biopsy devices. First, imaging-guided precision has moved from adjunctive support to a core functional requirement, driving deeper integration between hardware, software, and data analytics. As a result, manufacturers are prioritizing modular platforms that can accept multiple imaging inputs and deliver deterministic needle placement with feedback loops that reduce variability across operators.

Second, workflow optimization has become a commercial differentiator. Programs that reduce procedure time, lower complication rates, and simplify documentation attract system-level adoption. Consequently, design philosophies emphasize user-centered interfaces, automated needle deployment options, and cloud-enabled documentation that support procedural standardization. Third, convergence with digital health has introduced new monetizable services-software-as-a-service models, image analytics subscriptions, and outcome-tracking modules-that augment device revenue and deepen customer relationships.

Finally, competitive dynamics are changing as well. Smaller agile entrants are pursuing niche clinical applications and novel needle geometries, while established medtech firms leverage scale to bundle devices, imaging systems, and service contracts. Partnerships between imaging providers, software developers, and procedural device manufacturers are increasingly common, reflecting a recognition that integrated solutions win in complex clinical pathways. Altogether, these shifts demand that stakeholders rethink product roadmaps, clinical validation strategies, and go-to-market models to capture both clinical value and economic upside.

How 2025 tariff shifts have pressured supply chains, procurement behavior, and product strategies across device manufacturing and clinical adoption pathways

The cumulative impact of tariff actions announced in 2025 has introduced tangible operational and strategic consequences for supply chain configurations and cost structures across the smart biopsy device value chain. Tariff measures affecting medical device components and precision alloys have compelled manufacturers to re-evaluate supplier portfolios, accelerate supplier qualification in tariff-exempt jurisdictions, and consider localized assembly to mitigate increased landed costs. In many cases, these adjustments introduced project management overhead and inventory build-up as firms sought to hedge against supply interruptions and fiscal uncertainty.

Moreover, the tariff environment has influenced procurement behaviors among end users. Hospitals and diagnostic centers facing constrained capital budgets have heightened scrutiny on total cost of ownership, which includes not only acquisition cost but also maintenance, consumables, and the downstream operational impact of device selection. In response, vendors have emphasized transparency around component sourcing and lifecycle costs, and some have proposed alternative commercial terms-such as consumable bundling or service-inclusive agreements-to maintain competitiveness.

From a product innovation perspective, the tariff landscape has accelerated two notable responses. One, developers are exploring design simplification and material substitution where clinically acceptable, reducing reliance on high-tariff inputs. Two, companies are prioritizing differentiation through software and service layers that are less exposed to tariff fluctuations, thereby protecting margins and preserving value capture. Transitioning manufacturing footprints and diversifying supplier bases will remain an active management priority as firms seek to balance regulatory compliance, cost stability, and uninterrupted clinical supply.

Deep segmentation-driven analysis revealing how product, application, guidance technology, end-user, and component distinctions shape clinical and commercial pathways

Segmentation analysis provides a structured lens for identifying where clinical need, technological capability, and commercial opportunity intersect. Based on Product Type, market participants differentiate offerings between Automated and Manual platforms, with automation delivering workflow consistency and manual devices offering procedural familiarity for many operators. This dichotomy informs both product design and training investments, as automated solutions require tighter software-hardware integration while manual platforms prioritize ergonomics and tactile feedback.

Based on Application, clinical focus areas span Breast, Liver, Lung, and Prostate procedures, each presenting distinct anatomic and procedural constraints that shape device requirements. Breast biopsies emphasize cosmetic outcomes and outpatient procedural efficiency; liver and lung procedures demand robust imaging guidance to navigate respiratory motion and tissue heterogeneity; prostate biopsies require high spatial accuracy to align diagnostic sampling with targeted therapy planning. These application-specific imperatives drive needle design, imaging compatibility, and clinical training curricula.

Based on Guidance Technology, devices are evaluated across CT Guided, MRI Guided, and Ultrasound Guided modalities. CT guidance offers high-resolution anatomic localization in thoracic and hepatic interventions, MRI guidance excels in soft-tissue contrast and targeted prostate procedures, and ultrasound guidance provides real-time feedback and cost-effective portability. Interoperability across these guidance technologies is increasingly important as institutions seek flexible platforms that can be deployed across multiple procedure types.

Based on End User, adoption occurs across Ambulatory Surgical Centers, Clinics, Diagnostic Centers, and Hospitals, each with unique procurement cycles, staffing models, and throughput expectations. Ambulatory surgical centers and diagnostic centers often prioritize throughput and per-procedure cost efficiency, while hospitals focus on integration with broader imaging fleets and cross-departmental support. Clinics may value compact footprint and ease of use for office-based procedures.

Based on Component, device ecosystems are comprised of Accessories, Guidance Software, Imaging Systems, and Needles. Needles are further categorized across Large Gauge, Medium Gauge, and Small Gauge variants to accommodate different tissue types, sample volume needs, and clinician preferences. Component-level differentiation-such as needle lumen design, software navigation fidelity, and accessory ergonomics-drives clinician choice and impacts re-order cycles for consumables. By mapping segmentation layers to clinical workflows, stakeholders can better prioritize R&D investments and commercialization strategies that align with end-user economics and procedural outcomes.

Comparative regional dynamics and strategic imperatives highlighting how clinical priorities, regulation, and infrastructure influence device adoption across global markets

Regional dynamics exhibit distinct clinical priorities, regulatory environments, and procurement behaviors that influence adoption patterns and partnership strategies. In the Americas, healthcare delivery systems are characterized by a high degree of specialization, advanced imaging infrastructure, and a strong emphasis on minimally invasive diagnostic pathways. These factors favor devices that demonstrate procedural efficiency, reimbursement alignment, and interoperability with existing imaging platforms. Moreover, payer sensitivity and hospital budget cycles often dictate procurement timing and the uptake of higher-cost integrated solutions.

In Europe, Middle East & Africa, heterogeneous regulatory regimes and varied capital intensity produce differentiated adoption timelines across subregions. Established markets in Western Europe prioritize conformity with stringent regulatory and safety standards, while emerging markets within the region focus on cost-effective solutions and scalable training models. Middle Eastern and African markets often present opportunities for partnership-based distribution models and localized servicing agreements, reflecting logistical complexities and diverse clinical infrastructure.

In the Asia-Pacific region, rapid investment in imaging capacity and a growing emphasis on early detection and minimally invasive care are catalyzing demand for devices that can be rapidly deployed and supported at scale. Several APAC markets are also notable for fast adoption of novel procedural workflows and for demand-driven customization to local clinical practices. Cross-border supply chain considerations and regional trade agreements further influence sourcing decisions, as manufacturers weigh proximity to growing centers of demand against manufacturing cost advantages. Overall, regional strategy must be adaptive, combining regulatory pathway planning with tailored commercial models that reflect local payer systems, clinical practice patterns, and infrastructure maturity.

Competitive landscape and partnership strategies that differentiate leaders through clinical evidence, integrated services, and scalable commercialization models

Competitive dynamics in the smart biopsy domain are shaped by a mix of established medical device firms, imaging system providers, nimble startups focused on niche procedural needs, and software-first companies that deliver navigation and analytics capabilities. These players differentiate through clinical evidence generation, system integration, after-sales service, and strategic partnerships. Firms that can demonstrate clear outcomes advantages-reduced complication rates, higher diagnostic yield, or improved workflow efficiency-tend to build stronger institutional relationships and justify premium contracting models.

In addition to product differentiation, route-to-market execution is a critical determinant of commercial success. Sales channel structures range from direct hospital partnerships and integrated imaging sales to distributor networks serving ambulatory and clinic environments. Service offerings that include training, maintenance, and consumable supply management are increasingly central to customer retention, and companies that align commercial incentives with clinical outcomes find it easier to negotiate value-based contracts.

Technology alliances are another key vector for competitive advantage. Collaborations with imaging manufacturers, cloud analytics providers, and clinical research networks accelerate time-to-evidence and broaden addressable use cases. Meanwhile, intellectual property around needle tip geometry, navigation algorithms, and software workflows creates defensive moats. The most resilient companies combine product excellence with scalable service models and a clear playbook for clinical validation across different procedure types and care settings.

Actionable multi-dimensional recommendations for manufacturers and healthcare leaders to secure supply resilience, clinical validation, and sustainable commercial differentiation

Industry leaders should adopt a multipronged strategy that balances near-term operational resilience with long-term platform differentiation. First, prioritize supply chain diversification and nearshoring where economically feasible to reduce exposure to trade policy volatility and to shorten lead times for critical components. This step should be accompanied by rigorous supplier qualification processes and scenario planning to maintain continuity for high-volume consumables such as needles and imaging accessories.

Second, invest in clinical evidence generation that aligns with the most commercially meaningful applications. Targeted prospective studies in breast, lung, liver, and prostate procedures that measure diagnostic yield, complication rates, and workflow efficiency will accelerate payer acceptance and hospital procurement decisions. Pair these studies with real-world evidence captured through integrated software to demonstrate longitudinal value.

Third, design modular platforms that enable cross-modal compatibility with CT, MRI, and ultrasound guidance. Such interoperability increases platform utilization across departments and improves return on capital for purchasers. Complement product modularity with flexible commercial models-leasing, outcome-based contracts, and bundled consumables-to address diverse purchasing preferences across hospitals, diagnostic centers, clinics, and ambulatory surgical centers.

Fourth, accelerate digital strategy by embedding guidance software, analytics, and remote support capabilities into product offerings. Digital features not only enhance procedural accuracy but also create recurring revenue pathways that are less sensitive to component tariffs. Finally, cultivate targeted channel partnerships and service infrastructures to ensure rapid deployment and high uptime in key regional markets, thereby strengthening customer loyalty and competitive differentiation.

A rigorous mixed-methods research framework that blends clinician interviews, supply chain analysis, regulatory review, and expert validation to ensure robust actionable insights

The research approach integrates qualitative and quantitative methods designed to triangulate market dynamics, clinical adoption drivers, and competitive positioning. Primary research included structured interviews with clinicians across specialties-radiology, interventional oncology, and urology-alongside procurement leaders at hospitals, ambulatory surgical centers, and diagnostic centers to capture firsthand perspectives on device requirements, workflow constraints, and purchasing criteria. These interviews were complemented by discussions with device engineers, regulatory specialists, and component suppliers to map development timelines and sourcing considerations.

Secondary research entailed systematic review of clinical literature, regulatory filings, and publicly available technical documentation to validate clinical claims and device feature sets. Where helpful, procedural guidelines and best-practice statements were synthesized to contextualize clinical utility. Data triangulation techniques were used to reconcile differing inputs, and sensitivity analysis framed how operational changes-such as tariff-driven cost pressures or shifts in reimbursement policy-could alter procurement calculus.

Throughout the process, findings were validated via expert panels comprising clinicians, health system administrators, and industry strategists to ensure pragmatic relevance. The methodology emphasizes transparency in assumptions, traceability of sources, and reproducibility of analytical steps so that stakeholders can apply insights directly to product planning, clinical trials design, and go-to-market execution.

A concise synthesis of clinical, technological, and strategic drivers that will determine which biopsy device strategies translate into sustained clinical adoption and commercial success

In summary, the evolution of smart biopsy devices reflects a broader shift toward integrated procedural solutions that combine precision guidance, optimized workflows, and software-enabled value capture. Clinical demand for minimally invasive, high-fidelity sampling is intersecting with technological progress in imaging and navigation, producing opportunities for differentiated platforms that can serve multiple applications and clinical environments. At the same time, external pressures-such as tariff changes and regional regulatory variation-are compelling manufacturers to reorient supply chains and commercial models to preserve margin and ensure uninterrupted clinical supply.

Moving forward, success will accrue to organizations that can demonstrate measurable clinical benefits, provide flexible commercial options tailored to diverse end users, and embed software-driven services that enhance procedural outcomes and create recurring revenue. The interplay between segmentation choices-product type, application, guidance technology, end-user, and component design-and regional strategy will determine which offerings scale effectively. For decision-makers, the imperative is to align R&D priorities with validated clinical needs, operational realities, and adaptable go-to-market tactics so that innovations translate into sustainable clinical adoption and long-term institutional partnerships.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence for enhanced real time image guided biopsy decisions
  • 5.2. Development of sensor embedded biopsy needles for precise tissue characterization and feedback
  • 5.3. Adoption of robotic assisted biopsy platforms to improve procedural accuracy and workflow efficiency
  • 5.4. Emergence of point of care integrated molecular diagnostics for immediate biopsy sample analysis and decision support
  • 5.5. Growing use of MRI ultrasound fusion techniques in smart biopsy systems for targeted cancer detection
  • 5.6. Introduction of disposable smart biopsy kits designed for infection control and cost effective single use procedures
  • 5.7. Expansion of cloud based data management and telemedicine integration for remote biopsy procedure oversight
  • 5.8. Increasing regulatory approvals and reimbursement coverage shaping smart biopsy device market growth dynamics
  • 5.9. Advances in deep learning algorithms for automated lesion detection and biopsy targeting recommendations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Smart Biopsy Devices Market, by Product Type

  • 8.1. Automated
  • 8.2. Manual

9. Smart Biopsy Devices Market, by Application

  • 9.1. Breast
  • 9.2. Liver
  • 9.3. Lung
  • 9.4. Prostate

10. Smart Biopsy Devices Market, by Guidance Technology

  • 10.1. CT Guided
  • 10.2. MRI Guided
  • 10.3. Ultrasound Guided

11. Smart Biopsy Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals

12. Smart Biopsy Devices Market, by Component

  • 12.1. Accessories
  • 12.2. Guidance Software
  • 12.3. Imaging Systems
  • 12.4. Needles
    • 12.4.1. Large Gauge
    • 12.4.2. Medium Gauge
    • 12.4.3. Small Gauge

13. Smart Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Smart Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Smart Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. General Electric Company
    • 16.3.2. Siemens Healthineers AG
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. Hologic, Inc.
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. Hitachi, Ltd.
    • 16.3.8. Becton, Dickinson and Company
    • 16.3.9. Cook Medical LLC
    • 16.3.10. Merit Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SMART BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SMART BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SMART BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LARGE GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SMALL GAUGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 267. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GCC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. GCC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. GCC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 274. GCC SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 275. GCC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. GCC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 278. GCC SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 279. GCC SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 280. GCC SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 309. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. G7 SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. G7 SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. G7 SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. G7 SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. G7 SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. G7 SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. G7 SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. G7 SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 320. G7 SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 321. G7 SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 322. G7 SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 323. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. NATO SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. NATO SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. NATO SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. NATO SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. NATO SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 330. NATO SMART BIOPSY DEVICES MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 331. NATO SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. NATO SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 334. NATO SMART BIOPSY DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 335. NATO SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 336. NATO SMART BIOPSY DEVICES MARKET SIZE, BY NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 337. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. UNITED STATES SMART BIOPSY DEVICES MAR